Olivier Brandicourt is Director of Vaxcyte, Inc.. Currently has a direct ownership of 1,148 shares of PCVX, which is worth approximately $38,171. The most recent transaction as insider was on Jun 12, 2025, when has been sold 1,148 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15K
n/a 3M change
n/a 12M change
Total Value Held $38,171

OLIVIER BRANDICOURT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2025
BUY
Grant, award, or other acquisition
-
1,148 Added 50.0%
1,148 Common Stock

Also insider at

ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
BGNE
BeiGene, Ltd. Healthcare
OB

Olivier Brandicourt

Director
Cambridge, MA

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX